Your browser doesn't support javascript.
loading
Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancer.
Di Gioia, Dorit; Dresse, Marie; Mayr, Doris; Nagel, Dorothea; Heinemann, Volker; Stieber, Petra.
Afiliação
  • Di Gioia D; Department of Internal Medicine III, Ludwig-Maximilians-University of Munich, Campus Großhadern, 81377 Munich, Germany. Electronic address: Dorit.DiGioia@med.uni-muenchen.de.
  • Dresse M; Institute of Laboratory Medicine, Ludwig-Maximilians-University of Munich, Campus Großhadern, 81377 Munich, Germany.
  • Mayr D; Department of Pathology, Ludwig-Maximilians-University of Munich, 80337 Munich, Germany.
  • Nagel D; Institute of Laboratory Medicine, Ludwig-Maximilians-University of Munich, Campus Großhadern, 81377 Munich, Germany.
  • Heinemann V; Department of Internal Medicine III, Ludwig-Maximilians-University of Munich, Campus Großhadern, 81377 Munich, Germany.
  • Stieber P; Institute of Laboratory Medicine, Ludwig-Maximilians-University of Munich, Campus Großhadern, 81377 Munich, Germany.
Clin Chim Acta ; 440: 16-22, 2015 Feb 02.
Article em En | MEDLINE | ID: mdl-25444743
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Mucina-1 Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Mucina-1 Idioma: En Ano de publicação: 2015 Tipo de documento: Article